Randomized Phase 2 Study in BRAF Mutated CRC Patients

Randomized Phase 2 Study in BRAF Mutated CRC Patients

User Photo
obr

3 years
1,166 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jeffrey A. Meyerhardt, MD of Dana Farber Cancer Institute gives an overview of the outcomes of the randomized phase 2 study in BRAF mutated patients with colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (Annual Meeting GI) in San Francisco, CA.
Up Next Autoplay